News

Neurobiogen Co Ltd. has synthesized monoamine oxidase-B (MAO-B) inhibitors reported to be useful for the treatment of Parkinson’s disease.
Department of Bioengineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, ...